Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VKTX
#1287
Viking Therapeutics, Inc
33.8
4
+6.28%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+6.28%
Mudança mensal
+7.46%
Mudança em 6 meses
+25.94%
Mudança anual
+20.43%
Fechamento anterior
31.8
4
Open
33.8
4
Bid
Ask
Low
33.8
4
High
33.8
4
Volume
112
Mercados
Ações
Cuidados de saúde
VKTX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
74.13 M
78.36 M
78.42 M
100.49 M
112.25 M
115.55 M
—
Valuation ratios
Enterprise value
388.25 M
334.1 M
631.49 M
1.78 B
4.49 B
3.9 B
12.39 B
Price to earnings ratio
-10.35
-6.46
-9.47
-20.09
-39.84
-11.03
-61.39
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
-18.77
-7.46
-13.53
-23.5
-49.98
-14.22
-66.31
Price to book ratio
1.67
1.76
4.5
4.95
4.98
6.2
8.7
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.26
0.41
0.23
0.12
0.5
0.47
Return on equity %
0.16
0.27
0.47
0.25
0.12
0.56
0.51
Return on invested capital %
11.89 K
49.99 K
28.77 K
23.85 K
37.93 K
169 K
120.49 K
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
21.12
23.98
7.61
19.19
33.09
9.33
107.78
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.3
0.62
0.63
0.78
0.81
2.47
2.48
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.42
2.62
2.02
3.84
8.28
6.26
27.43
Net current asset value per share
3.53
2.73
2.17
3.89
8.32
6.35
28.03
Tangible book value per share
3.37
2.62
1.89
3.69
8.07
5.67
26.67
Working capital per share
3.36
2.61
1.89
3.69
8.07
5.67
26.66
Book value per share
3.37
2.62
1.89
3.69
8.07
5.67
26.67
Notícias
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
American Express, Oracle among market cap stock movers on Monday
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?
Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)
Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)
Cisco and Micron among market cap stock movers on Thursday
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report